Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH

ClinicalTrials.gov ID: NCT01966614

Public ClinicalTrials.gov record NCT01966614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of a Single Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (The PLUS 1 Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of a single treatment of PRX302 for the treatment of Benign Prostatic Hyperplasia (BPH) as compared to placebo.

Study identification

NCT ID
NCT01966614
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sophiris Bio Corp
Industry
Enrollment
479 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2013 (Type not available)
Primary completion
Dec 2015 (Actual)
Completion
Dec 2015 (Actual)
Last update posted
Apr 27, 2017

2013 – 2015

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Anchorage Alaska 99503 —
Not listed Laguna Hills California 92653 —
Not listed Long Beach California 90806 —
Not listed Los Angeles California 90017 —
Not listed Newport Beach California 92660 —
Not listed San Diego California 92120 —
Not listed San Diego California 92123 —
Not listed Tarzana California 91356 —
Not listed Denver Colorado 80220 —
Not listed Middlebury Connecticut 06762 —
Not listed Aventura Florida 33180 —
Not listed Coral Gables Florida 33134 —
Not listed Pompano Beach Florida 33060 —
Not listed St. Petersburg Florida 33770 —
Not listed Wellington Florida 33449 —
Not listed Coeur d'Alene Idaho 83814 —
Not listed Meridian Idaho 83642 —
Not listed Springfield Illinois 62701 —
Not listed Jeffersonville Indiana 47130 —
Not listed West Des Moines Iowa 50266 —
Not listed Baltimore Maryland 21204 —
Not listed Baltimore Maryland 21237 —
Not listed Greenbelt Maryland 20770 —
Not listed Towson Maryland 21204 —
Not listed Brookline Massachusetts 02445 —
Not listed Missoula Montana 59808 —
Not listed Mount Laurel New Jersey 08054 —
Not listed Albuquerque New Mexico 87109 —
Not listed Garden City New York 11530 —
Not listed New York New York 10016 —
Not listed Newburgh New York 12550 —
Not listed Poughkeepsie New York 12601 —
Not listed The Bronx New York 10457 —
Not listed Concord North Carolina 28025 —
Not listed Raleigh North Carolina 27612 —
Not listed Bala-Cynwyd Pennsylvania 19004 —
Not listed Bryn Mawr Pennsylvania 19010 —
Not listed Greer South Carolina 29650 —
Not listed Myrtle Beach South Carolina 29572 —
Not listed Carrollton Texas 75010 —
Not listed Dallas Texas 75390 —
Not listed Houston Texas 77030 —
Not listed Salt Lake City Utah 84124 —
Not listed Burien Washington 98166 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01966614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01966614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →